2Di Napoli P,Taccardi AA,Bardotti A.Long term cardio-protective action of trimetazidine and potential effect on the inflammatory process in patients with ischemic dilated cardiomyopathy.Heart,2005,92(2):161-165.
3Kantor PF,Lucien A,Kozak R,et al.The anti-angina drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.Circ Res,2000,86:580-588.
4Feola M,Biggi A,Francini A,et al.Placebo of trimetazidine(99 m) Tc Tetrofosm in myocardial SPECT and low-dose dobutamine echocardiography in liberating myocardium.Arch Med Res,2006,37(1):117-122.
7Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
8Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
9Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
10Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
6Darago A,Fagyas M,Siket I M. Differences in angiotensin convertase enzyme(ACE) activity and expression may contribute to shorter event free period after coronary artery bypass graft surgery[J].Cardiovasc Ther,2012,(03):136-144.
